Article
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling.
Oncotarget - 2 Feb 2016
Mediani Laura, Gibellini Federica, Bertacchini Jessika, Frasson Chiara, Bosco Raffaella, Accordi Benedetta, Basso Giuseppe, Bonora Massimo, Calabrò Maria Luisa, Mattiolo Adriana, Sgarbi Gianluca, Baracca Alessandra, Pinton Paolo, Riva Giovanni, Rampazzo Enrico, Petrizza Luca, Prodi Luca, Milani Daniela, Luppi Mario, Potenza Leonardo, De Pol Anto, Cocco Lucio, Capitani Silvano, Marmiroli Sandra
Abstract excerpt
PEL is a B-cell non-Hodgkin lymphoma, occurring predominantly as a lymphomatous effusion in body cavities, characterized by aggressive clinical course, with no standard therapy. Based on previous reports that PEL cells display a Warburg phenotype, we hypothesized that the highly hypoxic environment in which they grow in vivo makes them more reliant on glycolysis, and more vulnerable to drugs targeting this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
